WARF Accelerator will award 2-5 grants from a $100K pool
CONTACT:
Jeanan Yasiri Moe
Director of Strategic Communications and Public Affairs
[email protected] | (608) 960-9892
MADISON, Wis. – The Wisconsin Alumni Research Foundation and Nexus NeuroTech Ventures have teamed together to launch a spring challenge aimed at advancing innovative neurotechnologies. Principal Investigators (PIs) and their teams are invited to submit a brief disclosure form and questionnaire by April 1, 2025.
“Nexus NeuroTech Ventures is committed to accelerating the next wave of neurotechnology innovation,” says John Propst, Head of Incubator Operations at Nexus NeuroTech Ventures. “This initiative with WARF is an opportunity to identify promising ideas at UW-Madison and help transform them into tangible solutions that can make a real difference for people living with brain disorders.”
Projects (even early-stage) that advance novel technologies for diagnosing and treating brain disorders such as but not limited to Parkinson’s disease or bipolar disorder, along with cross-cutting clinical areas including seizures, cognitive dysfunction and mood disorders, will be considered. Approaches could leverage medical devices, research tools, software, diagnostics and more, driving toward the goal of significantly improving patient outcomes. Proposed research should be completed within a year.
Submissions are due to WARF by April 1. Criteria include:
- Project team must include a PI at UW-Madison or Morgridge Institute for Research
- Concepts must be new (not previously disclosed to WARF)
- Technical readiness
- Commercial potential
“We want to recognize and support UW-Madison researchers who are developing groundbreaking diagnostic and treatment methods for neurological conditions,” says Erik Iverson, CEO of WARF. “Through our collaboration with Nexus NeuroTech Ventures, we aim to advance innovative solutions to these critical health challenges.”
For questions contact Jeanine Burmania, senior director, IP & licensing, at [email protected], 608-960-9846.
About WARF
The Wisconsin Alumni Research Foundation (WARF) helps steward the cycle of research, discovery, commercialization and investment for the University of Wisconsin–Madison and provides annual support to the university to advance research and innovation. Founded in 1925 as an independent, nonprofit foundation, WARF manages more than 2,000 patents and an investment portfolio as it funds university research, obtains patents for campus discoveries and licenses inventions to industry. For more information, visit warf.org and view WARF’s Cycle of Innovation.
About Nexus NeuroTech Ventures
Nexus NeuroTech Ventures is an investment firm dedicated to advancing pioneering technologies — including medical devices, software, diagnostics, technology-enabled care services and research tools — for brain disorders. Spanning seed through crossover, Nexus invests with the goal of improving the lives of people affected by neurodevelopmental, neurodegenerative and neuropsychiatric conditions. See nexusneurotech.com for more information.
###